David Windley
Stock Analyst at Jefferies
(4.67)
# 784
Out of 4,455 analysts
808
Total ratings
58.6%
Success rate
9.2%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Reiterated: Buy | $135 → $193 | $169.86 | +13.62% | 74 | Jun 25, 2026 | |
| MEDP Medpace Holdings | Maintained: Buy | $560 → $490 | $527.07 | -7.03% | 34 | Jun 15, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $225 | $215.75 | +4.29% | 75 | May 8, 2026 | |
| CNC Centene | Maintained: Hold | $43 → $39 | $65.73 | -40.67% | 88 | Apr 20, 2026 | |
| CI The Cigna Group | Maintained: Buy | $336 → $330 | $282.79 | +16.69% | 64 | Apr 20, 2026 | |
| MOH Molina Healthcare | Maintained: Hold | $160 → $139 | $229.74 | -39.50% | 60 | Apr 20, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $340 → $373 | $427.89 | -12.83% | 73 | Apr 20, 2026 | |
| ELV Elevance Health | Maintained: Buy | $370 → $391 | $395.18 | -1.06% | 77 | Apr 20, 2026 | |
| OSCR Oscar Health | Upgraded: Hold | $12 → $16 | $29.79 | -46.29% | 7 | Apr 20, 2026 | |
| HUM Humana | Maintained: Buy | $235 | $383.84 | -38.78% | 68 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $365 → $295 | $350.85 | -15.92% | 42 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $18 | $17.84 | -1.91% | 15 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 → $255 | $191.14 | +33.41% | 59 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $17.38 | +12.20% | 14 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $9.5 | $17.65 | -46.18% | 3 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.75 → $3 | $0.8237 | +264.21% | 2 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $263 | $215.67 | n/a | 2 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $2.5 | $0.012 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $335 | $171.36 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $15 | $5.84 | n/a | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $177 → $190 | $49.42 | n/a | 3 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $200 → $248 | $8.39 | n/a | 5 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8.5 | $5.10 | n/a | 10 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.51 | n/a | 4 | Aug 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $328.69 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $1.52 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $3.34 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $169.03 | n/a | 1 | Nov 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $55.08 | n/a | 1 | Aug 27, 2009 |
ICON Public Limited Company
Jun 25, 2026
Reiterated: Buy
Price Target: $135 → $193
Current: $169.86
Upside: +13.62%
Medpace Holdings
Jun 15, 2026
Maintained: Buy
Price Target: $560 → $490
Current: $527.07
Upside: -7.03%
Charles River Laboratories International
May 8, 2026
Maintained: Buy
Price Target: $225
Current: $215.75
Upside: +4.29%
Centene
Apr 20, 2026
Maintained: Hold
Price Target: $43 → $39
Current: $65.73
Upside: -40.67%
The Cigna Group
Apr 20, 2026
Maintained: Buy
Price Target: $336 → $330
Current: $282.79
Upside: +16.69%
Molina Healthcare
Apr 20, 2026
Maintained: Hold
Price Target: $160 → $139
Current: $229.74
Upside: -39.50%
UnitedHealth Group
Apr 20, 2026
Maintained: Buy
Price Target: $340 → $373
Current: $427.89
Upside: -12.83%
Elevance Health
Apr 20, 2026
Maintained: Buy
Price Target: $370 → $391
Current: $395.18
Upside: -1.06%
Oscar Health
Apr 20, 2026
Upgraded: Hold
Price Target: $12 → $16
Current: $29.79
Upside: -46.29%
Humana
Feb 27, 2026
Maintained: Buy
Price Target: $235
Current: $383.84
Upside: -38.78%
Feb 10, 2026
Maintained: Buy
Price Target: $365 → $295
Current: $350.85
Upside: -15.92%
Feb 10, 2026
Maintained: Hold
Price Target: $21 → $18
Current: $17.84
Upside: -1.91%
Feb 6, 2026
Maintained: Buy
Price Target: $225 → $255
Current: $191.14
Upside: +33.41%
Nov 20, 2025
Maintained: Buy
Price Target: $16 → $20
Current: $17.38
Upside: +12.20%
Sep 8, 2025
Maintained: Hold
Price Target: $21 → $9.5
Current: $17.65
Upside: -46.18%
Aug 25, 2025
Maintained: Hold
Price Target: $2.75 → $3
Current: $0.8237
Upside: +264.21%
Jun 4, 2025
Maintained: Hold
Price Target: $263
Current: $215.67
Upside: n/a
Jun 2, 2025
Maintained: Hold
Price Target: $1.5 → $2.5
Current: $0.012
Upside: n/a
Jun 2, 2025
Maintained: Buy
Price Target: $280 → $335
Current: $171.36
Upside: n/a
Apr 21, 2025
Maintained: Hold
Price Target: $16 → $15
Current: $5.84
Upside: n/a
Apr 26, 2021
Maintained: Buy
Price Target: $177 → $190
Current: $49.42
Upside: n/a
Feb 25, 2021
Maintained: Hold
Price Target: $200 → $248
Current: $8.39
Upside: n/a
Aug 4, 2020
Rated: Hold
Price Target: $7 → $8.5
Current: $5.10
Upside: n/a
Aug 21, 2017
Reiterated: Buy
Price Target: $28
Current: $5.51
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $129
Current: $328.69
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $9.5
Current: $1.52
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $36
Current: $3.34
Upside: n/a
Nov 28, 2016
Reiterated: Hold
Price Target: $68
Current: $169.03
Upside: n/a
Aug 27, 2009
Downgraded: Hold
Price Target: $12
Current: $55.08
Upside: n/a